|
ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE
|
5R44CA114126-03
|
$419,983
|
$209,992
|
Lim, Mark
|
AMBERGEN, INC
|
|
AID-mediated genetic instability in BCR-ABL1-transformed B cell lineage leukemia
|
1R01CA139032-01
|
$332,000
|
$166,000
|
Muschen, Markus
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Basic Mechanisms of Viral and Chemical Carcinogenesis
|
3T32CA009156-35S1
|
$49,915
|
$9,983
|
PAGANO, JOSEPH
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Basic Mechanisms of Viral and Chemical Carcinogenesis
|
5T32CA009156-35
|
$1,105,050
|
$221,010
|
PAGANO, JOSEPH
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Biology & Transplantation of the Human Stem Cell
|
5P01CA065493-15
|
$2,135,909
|
$533,977
|
MCGLAVE, PHILIP
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Biosensor design for detection and analysis of complex signal patterns in cancer
|
5K99CA127161-02
|
$139,631
|
$69,816
|
Parker, Laurie
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
|
Bone Marrow Transplantation in Human Disease
|
5P01CA015396-34
|
$3,012,562
|
$602,512
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-34S1
|
$113,210
|
$1,132
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-34S2
|
$124,410
|
$1,244
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-34S3
|
$99,940
|
$999
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support (Core) Grant
|
5P30CA016672-34
|
$10,451,830
|
$104,518
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant
|
3P30CA033572-26S1
|
$94,753
|
$13,265
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-26S2
|
$107,415
|
$15,038
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-26S3
|
$100,000
|
$14,000
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-26
|
$2,342,475
|
$327,947
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$1,434
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$116,889
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA082103-11S1
|
$144,844
|
$8,691
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-11S2
|
$115,875
|
$6,953
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA082103-11
|
$7,585,971
|
$455,158
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA014599-34S1
|
$82,031
|
$4,102
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
Cancer Center Support Grant
|
5P30CA014599-34
|
$4,299,426
|
$214,971
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
Cancer Center Support Grant (CCSG)
|
3P30CA021765-31S1
|
$100,000
|
$2,000
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant (CCSG)
|
3P30CA021765-31S2
|
|
$0
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant (CCSG)
|
3P30CA021765-31S3
|
$126,000
|
$2,520
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant (CCSG)
|
5P30CA021765-31
|
$5,973,490
|
$119,470
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant (Comprehensive)
|
2P30CA015704-35
|
$10,977,925
|
$109,779
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-35S3
|
$249,999
|
$2,500
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-35S4
|
$85,601
|
$856
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-35S5
|
$100,000
|
$1,000
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (CORE)
|
3P30CA023168-29S3
|
$1,165,056
|
$11,651
|
RATLIFF, TIMOTHY
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
|
Cancer Center Support Grant (CORE)
|
3P30CA023168-29S4
|
$99,286
|
$993
|
RATLIFF, TIMOTHY
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-20S2
|
$70,196
|
$1,404
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-20S3
|
$99,890
|
$1,998
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-20
|
$4,865,452
|
$97,309
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CD45 Pretargeted Radioimmunotherapy for AML
|
2R01CA109663-05A1
|
$318,935
|
$63,787
|
Press, Oliver
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Chronic Lymphocytic Leukemia Research Consortium
|
3P01CA081534-10S1
|
$113,755
|
$56,878
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Chronic Lymphocytic Leukemia Research Consortium
|
5P01CA081534-10
|
$3,970,539
|
$1,985,270
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Chronic Myelogenous Leukemia and Bcr-Abl Substrates
|
5R01CA065823-15
|
$310,291
|
$310,291
|
DRUKER, BRIAN
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
City of Hope Lymphoma SPORE
|
3P50CA107399-05S1
|
$1,079,832
|
$269,958
|
forman, stephen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Clinical Oncology Research Training Program
|
2T32CA079447-11A1
|
$222,637
|
$33,396
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
Converting an Oncogene to an Apoptotic Factor by Manipulating Signal Sequences
|
5R01CA129528-02
|
$283,656
|
$283,656
|
LIM, CAROL
|
UNIVERSITY OF UTAH
|
|
Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD
|
5R01CA133063-02
|
$274,204
|
$137,102
|
Longnecker, Richard
|
NORTHWESTERN UNIVERSITY
|
|
Dynamics of Tumor Stem Cells in Cancer Initiation, Therapy, and Resistance
|
5R01CA138234-02
|
$513,998
|
$513,998
|
Michor, Franziska
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Etiology of Alkylator-Induced Myeloid Leukemia
|
5P01CA040046-22
|
$1,771,741
|
$885,871
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
Ex Vivo Alloanergization to Improve Immunity After Haploidentical Transplant
|
1R21CA137645-01A1
|
$370,550
|
$370,550
|
GUINAN, EVA
|
DANA-FARBER CANCER INSTITUTE
|
|
FASEB Conference-Hematological Malignancies
|
5R13CA117424-03
|
$9,710
|
$2,428
|
ZHANG, DONG-ER
|
FEDERATION OF AMER SOC FOR EXPER BIOLOGY
|
|
Flexible and Somatic Mouse Models for Myelodysplastic Syndrome Progression
|
5R21CA131522-02
|
$243,000
|
$243,000
|
MA, YUPO
|
NEVADA CANCER INSTITUTE
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $32,529,168
|